DS STAGE I MULTIPLE MYELOMA

Clinical trials for DS STAGE I MULTIPLE MYELOMA explained in plain language.

Never miss a new study

Get alerted when new DS STAGE I MULTIPLE MYELOMA trials appear

Sign up with your email to follow new studies for DS STAGE I MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Promising drug may delay myeloma return after transplant

Disease control Ongoing

This study tested whether taking lenalidomide (a drug that helps the immune system fight cancer) after a stem cell transplant could keep multiple myeloma from coming back longer than taking a placebo. About 460 people with active multiple myeloma took part. The goal was to see if…

Matched conditions: DS STAGE I MULTIPLE MYELOMA

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 29, 2026 00:35 UTC

DS STAGE I MULTIPLE MYELOMA

Get alerted when new DS STAGE I MULTIPLE MYELOMA trials appear

Promising drug may delay myeloma return after transplant